// App-Quantinova.ai

S1019 2016 AHA : Distinctive Functions of PI3K? in Endothelial Cells and Cardiomyocytes in Response to Myocardial Infarction: Complications for Targeting PI3K? in Myocardial Infarction Treatment

Researchers

Presenter

  • Pavel Zhabyeyev

Principal Investigators

  • Jessica DesAulniers

  • Xiuhua Wang

  • Faqi Wang

  • Allan G Murray

  • Zamaneh Kassiri

  • Bart Vanhaesebroeck

  • Gavin Y Oudit

Medical Centers

  • Kings College London, London, United Kingdom

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Cluster of Differentiation 31

Drug/Treatment

  • Tamoxifen

Outcome

  • N/A


Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim